DFCM
AGIO icon

Dark Forest Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

Dark Forest Capital Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-43
Closed -$1K – 863
2022
Q1 		$1K Buy
+43
New +$1.31K ﹤0.01% 1181
2021
Q4 		– Sell
-373
Closed -$17K – 1392
2021
Q3 		$17K Sell
373
-1,334
-78% -$64.4K 0.01% 860
2021
Q2 		$94K Buy
+1,707
New +$95.5K 0.04% 338

Other funds holding AGIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Dark Forest Capital Management's AGIO Position: Q2 2022 in Review

Dark Forest Capital Management sold out of Agios Pharmaceuticals (AGIO) in Q2 2022, closing a stake of 43 shares — an estimated $1K sold.

Dark Forest Capital Management first reported a position in AGIO in Q2 2021 and held it in 3 quarters. The position peaked at $94K in Q2 2021. 155 funds tracked by Wall St. Rank hold AGIO as of Q2 2022.

  • Dark Forest Capital Management reported no remaining Agios Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Dark Forest Capital Management sold 43 Agios Pharmaceuticals shares in Q2 2022, an estimated $1K.
  • Dark Forest Capital Management first reported a position in Agios Pharmaceuticals in Q2 2021 and held it in 3 quarters.
  • Dark Forest Capital Management's Agios Pharmaceuticals position peaked at $94K in Q2 2021.
  • 155 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2022.

Based on Dark Forest Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.